Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Antiaging Quantum Living (AAQL) EBITDA (2020 - 2025)

Antiaging Quantum Living (AAQL) has disclosed EBITDA for 6 consecutive years, with -$249021.0 as the latest value for Q4 2025.

  • Quarterly EBITDA fell 139.78% to -$249021.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$639165.0 through Dec 2025, up 19.18% year-over-year, with the annual reading at -$716847.0 for FY2025, 74.69% down from the prior year.
  • EBITDA hit -$249021.0 in Q4 2025 for Antiaging Quantum Living, down from -$64371.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$1520.0 in Q3 2022 to a low of -$258428.0 in Q1 2024.
  • Historically, EBITDA has averaged -$87768.1 across 5 years, with a median of -$29727.0 in 2023.
  • Biggest five-year swings in EBITDA: soared 80.08% in 2022 and later crashed 3472.9% in 2024.
  • Year by year, EBITDA stood at -$19310.0 in 2021, then surged by 64.93% to -$6772.0 in 2022, then crashed by 1344.61% to -$97829.0 in 2023, then dropped by 6.16% to -$103853.0 in 2024, then crashed by 139.78% to -$249021.0 in 2025.
  • Business Quant data shows EBITDA for AAQL at -$249021.0 in Q4 2025, -$64371.0 in Q3 2025, and -$141309.0 in Q2 2025.